Compounds > cystic fibrosis transmembrane conductance regulator (505-511)
Page last updated: 2024-09-03

cystic fibrosis transmembrane conductance regulator (505-511) and trypsinogen

cystic fibrosis transmembrane conductance regulator (505-511) has been researched along with trypsinogen in 1 studies

Compound Research Comparison

Studies
(cystic fibrosis transmembrane conductance regulator (505-511))		Trials
(cystic fibrosis transmembrane conductance regulator (505-511))		Recent Studies (post-2010)
(cystic fibrosis transmembrane conductance regulator (505-511))		Studies
(trypsinogen)		Trials
(trypsinogen)		Recent Studies (post-2010) (trypsinogen)
17131,96320297

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grendell, JH1

Reviews

1 review(s) available for cystic fibrosis transmembrane conductance regulator (505-511) and trypsinogen

ArticleYear
Genetic factors in pancreatitis.
    Current gastroenterology reports, 2003, Volume: 5, Issue:2

    Topics: Cystic Fibrosis Transmembrane Conductance Regulator; Genetic Predisposition to Disease; Humans; Mutation; Pancreatitis; Penetrance; Peptide Fragments; Point Mutation; Trypsin; Trypsin Inhibitor, Kazal Pancreatic; Trypsinogen

2003